NCT05820997View on ClinicalTrials.gov

Paravertebral Block Vs No Block in Open Pancreaticoduodenectomy

PHASE4TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

April 24, 2023

Primary Completion Date

December 4, 2024

Study Completion Date

December 4, 2024

Conditions

Pancreaticoduodenectomy

Interventions

DRUG

Ropivacaine

Paravertebral at the T7-10 levels bilaterally with 5 cc of 0.5% ropivacaine at each level

Trial Locations (1)

32224

Mayo Clinic Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER